Jim Cramer Blesses Rigel Pharmaceuticals as a Spec as “It’s Doing Better Than People Realize”

Jim Cramer reviewed Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) while breaking down 16 stocks for a market facing higher energy costs and economic uncertainty. When a caller asked about the stock during the lightning round, Cramer said: Okay, I think we, I have to tell you, I think that this company is real. It’s doing better than people realize. It is speculative. I bless it. I bless it as a spec. You can get one spec, as we say in How to Make Money in Any Market. You can get one spec, and that’s the spec ...